Stem Cells and Diabetes

Diabetes exacts its toll on many Americans, young and old. For years, researchers have painstakingly dissected this complicated disease caused by the destruction of insulin producing islet cells of the pancreas. Despite progress in understanding the underlying disease mechanisms for diabetes, there is still a paucity of effective therapies. For years investigators have been making slow, but steady, progress on experimental strategies for pancreatic transplantation and islet cell replacement. Now, researchers have turned their attention to adult stem cells that appear to be precursors to islet cells and embryonic stem cells that produce insulin.

Stem Cell Research

We strongly support the protection and expansion of all forms of stem cell research, which offer great hope for a cure and better treatments for diabetes. We support legislation and proposals that enhance funding for stem cell research at the federal and state levels.

Stem Cell Basics

Stem cells, directed to differentiate into specific cell types, offer the possibility of a renewable source of replacement cells and tissues to treat diseases including Alzheimer’s diseases, spinal cord injury, stroke, burns, heart disease, diabetes, osteoarthritis, and rheumatoid arthritis.

Stem Cells and Diabetes

Over the last several years, the Diabetes Research Institute has shown the extraordinary potential of cell replacement therapy to restore insulin function. Now, a major focus for us is to develop a reliable and unlimited supply of healthy insulin-producing cells to treat the many millions of people who can benefit from cell replacement therapies.

Stem cell expert confident of diabetes cure

Professor Alan Trounson has highlighted research that has transformed human embryonic stem cells into insulin-producing cells to treat diabetes in mice. He says the technique could work equally with humans. “I do think we’ll get a cure to diabetes,” he said.

Stem Cell Research

Stem cells are the essential cellular building blocks that allow the body to regenerate new cells and repair tissue. Scientists are investigating the therapeutic potential of both embryonic and adult stem cells as a research tool to better understand-and develop treatments for-diseases that affect over 100 million Americans in their lifetime, including diabetes, cancer, heart disease, spinal cord injuries, Alzheimer’s, Parkinson’s, and other debilitating conditions.

Osiris Completes Enrollment in Stem Cell Trial for Type 1 Diabetes

Osiris Therapeutics, Inc. today announced that it has achieved a $750,000 milestone payment from the Juvenile Diabetes Research Foundation (JDRF) for completing enrollment in a Phase II clinical trial evaluating Prochymal, an adult mesenchymal stem cell (MSC) therapy, as a treatment for patients recently diagnosed with type 1 diabetes. The milestone is the fourth in a series of payments resulting from JDRF’s partnership with Osiris for the development of a therapy for type 1 diabetes.

Stem Cell Therapy Helps Diabetes Limb Problems

Stem cell therapy aimed at restoring blood flow to damaged limbs in people with diabetes has shown promise, according to UK company ReNeuron.

Diabetics cured in stem-cell treatment advance

Diabetics using stem-cell therapy have been able to stop taking insulin injections for the first time, after their bodies started to produce the hormone naturally again.

Stem cells ‘cure diabetes’

“Stem cell transplants ‘have freed patients with type 1 diabetes of daily insulin injections’” The Daily Telegraph has said. The news comes after research which allowed volunteers to go, on average, for two and a half years without using the multiple daily injections normally needed to manage their condition.

Stem cell transplant ‘very encouraging’ for type 1 diabetes

A handful of people with type 1 diabetes have been able to survive without insulin shots for more than two-and-a-half years, on average, after having their own blood stem cells removed and reimplanted through intravenous injection, U.S. and Brazilian researchers reported Tuesday.

Study: Stem Cells May Reverse Type 1 Diabetes

Researchers have used injections of patients’ own stem cells to reverse the course of type 1 diabetes, reports a research team from the University of São Paulo in Brazil and Northwestern University in Chicago.

Stem Cell Transplants May be the Future Cure for Diabetes

The study involved the use of a technique called “autologous hematopoietic stem cell transplantation” or AHST for short. This type of treatment has been used to treat other autoimmune diseases successfully. Previous trials have shown that moderate suppression of the immune system in newly diagnosed Type 1 diabetes patients can stop the further loss of beta cells and reduce the need for supplemental insulin.

Stem cell success for diabetes

A news story this past week caught my attention: The New York Times published a story, Stem Cell Therapy Controls Diabetes in Mice, that seemed worth reading — although it was clear that the research was sponsored by a biotechnology company, Novocell. They have a press release about their new research at their website, Novocell Reports Successful Use of Stem Cells to Generate Insulin in Mice.

Diabetes stem-cell treatment looks to cell capsules

Patients with diabetes can show vast improvement after receiving transplants of insulin-producing islets from cadavers. Though they must take drugs to stall rejection of the transplanted cells, several hundred patients with the most severe type of diabetes have benefited from the procedure since it first became established in 2000. But the effects don’t last. After two years, islet function begins to decline, and unless more cells are transplanted, patients eventually return to full insulin dependency.

Stem cell treatment of Diabetes mellitus type 1 & 2

Our innovative, autologous (originating from your own body) stem cell therapy for diabetes I and II does just that – drug free. It fights diabetes at its roots, reducing hyperglycemia and its associated complications (see above). Recent evidence suggests that it also reduces hypoglycemic (low blood sugar) events that can result in death if not treated promptly.

Research and Markets: Cell and Stem Cell Therapies for Diabetes – Addressing Advances in Research and Development of Pancreatic Islet Cell and Stem Cell Therapies

Pancreatic islet cell transplantation and particularly stem cell-based therapies have a huge potential to restore glucose control in patients with diabetes, without risk of serious hypoglycemic adverse effects associated with insulin therapy, and safety issues of other anti-diabetes treatments.

Stem Cell Therapy Controls Diabetes in Mice

Scientists reported on Wednesday that they were able to control diabetes in mice by harnessing human embryonic stem cells. The work raised the prospect that the embryonic cells might one day be used to provide insulin-producing replacement cells to treat the disease in people.

Stem Cell Research

Scientists believe that stem cells have the potential to cure many diseases, including type 1 diabetes. Stem cells are a type of basic cell that scientists hope can grow to be any other type of cell, such as a muscle, nerve, or beta cell. For people with type 1 diabetes, the hope is that stem cells can be made into insulin-producing beta cells in vast quantities and that these engineered beta cells can be transplanted into people with type 1 diabetes, curing them of the disease.

What is stem cell tourism?

In Australia, and many other countries around the world, stem cell therapy is only approved to treat blood disorders such as leukemia. Whilst research is moving rapidly and showing great promise, the use of any type of stem cell as a therapy for diseases like type 1 diabetes is still firmly classed as experimental. This doesn’t mean these therapies won’t work, just that scientists and clinicians have deemed there isn’t enough data available to demonstrate patient safety as well as a long term benefit.

Stem cells could spell end for diabetes jabs

Hopes have been raised of a new treatment to free thousands of diabetes sufferers from the burden of daily insulin injections. Scientists revealed findings of a study which shows that 15 young patients with type one diabetes overcame their dependence on insulin after being treated with their own stem cells.

Stem cell research and diabetes

Stem cell research is a relatively new area of investigation, believed by many in the scientific and medical communities to have important new potential for the treatment of many diseases and conditions particularly those like diabetes, which are characterised by severe damage to certain cells and tissues. We cannot know what benefits any particular avenue of research may yield in the long term. The potential of human stem cell research is that it could lead to the identification of the pathway that results in the production of functioning, insulin-producing islet cells. This could provide potentially limitless supplies of islet cells to become available for transplantation (see below for more information).

Diabetes And Stem Cell Research

If it were effective, stem cell replacement would simply be a case of swapping insulin-producing cells from a healthy pancreas with those destroyed by diabetes in a diabetic patient. However, numerous complications preclude this as a simple treatment. Pancreas transplants are one form of procedure that has proven effective. However, the demand far outstrips supply and the procedure is expensive. Furthermore, to prevent the immune system from rejecting a new pancreas, the patient must take immuno-suppressant drugs.

Stem Cells Promising for Type 1 Diabetes

Insulin No Longer Needed by Some Diabetic Patients Who Underwent Experimental Treatment

What is Diabetes? Latest stem cell research for Diabetes

Some people with Type 1 diabetes who received an experimental stem-cell treatment have been able to go for up to four years without needing insulin, researchers claimed yesterday. However, Diabetes UK says much more research is needed.